Pfizer pharmaceuticals news

Pfizer launched the Global Centers for Therapeutic Innovation to establish partnerships with academic medical centers for drug discovery and development. The pharma said the University of California, San Francisco, will be the first partner in the network. Under the initiative, Pfizer will provide its partners with funding for preclinical and clinical development programs, as well as offer IP and ownership rights, in return for options to license exclusive rights to drug candidates. Academic partners will have access to Pfizer's antibody libraries and research and also will be eligible for milestones and royalties on advanced programs. ...